摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(7-chloro-2,3-dimethoxyquinoxalin-5-yl)methanesulfonamide | 947725-18-0

中文名称
——
中文别名
——
英文名称
N-(7-chloro-2,3-dimethoxyquinoxalin-5-yl)methanesulfonamide
英文别名
——
N-(7-chloro-2,3-dimethoxyquinoxalin-5-yl)methanesulfonamide化学式
CAS
947725-18-0
化学式
C11H12ClN3O4S
mdl
——
分子量
317.753
InChiKey
UKSBFULDFGMSRJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.67
  • 重原子数:
    20.0
  • 可旋转键数:
    4.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    90.41
  • 氢给体数:
    1.0
  • 氢受体数:
    6.0

反应信息

  • 作为反应物:
    描述:
    N-(7-chloro-2,3-dimethoxyquinoxalin-5-yl)methanesulfonamide盐酸potassium carbonate 作用下, 以 乙腈 为溶剂, 反应 10.0h, 生成 N-(7-chloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-(3-methoxypropyl)methanesulfonamide
    参考文献:
    名称:
    N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain
    摘要:
    It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.05.083
  • 作为产物:
    参考文献:
    名称:
    N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain
    摘要:
    It has been hypothesized that peripherally restricted NMDA receptor antagonists may be effective analgesics for osteoarthritis pain. A class of novel quinoxalinedione atropisomers, first discovered for an NMDA receptor antagonist program for the treatment of stroke, was evaluated and further optimized with the goal of finding peripherally restricted NMDA receptor antagonists. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.05.083
点击查看最新优质反应信息